Searched for
THIRD DOSE
For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Warren Buffett on why bubbles end badly – even when everyone knows they willWarren Buffett compared bubble investors to Cinderella at the ball: Everyone plans to leave just before midnight, but they are dancing in a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Pregabalin moved to Schedule H1 as centre cracks down on drug misusePregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Covaxin third jab boosts antibody response against several Covid strains: StudyBharat Biotech said the “comprehensive” study has demonstrated multiple benefits of its vaccine, including long-term immune response, cell-...
- Third time dose, not just for the luckyAt ₹225 for the third vaccine, with an additional ₹150 for service charge for the jab itself, could push a sizeable section of the populati...
- Some experts are worried over move to use the same vaccine as booster doseThe third dose of the Covid vaccine to be given to healthcare workers, frontline workers and those aged 60 years and above with comorbiditi...
- Third vaccine dose can boost effectiveness against Omicron to 88%, UK studies showThe findings compiled in a report by the UK Health Security Agency (UKSHA) show significantly higher protection provided by third vaccine d...
- NTAGI, working group to take call on 3rd dose for IndiaNTAGI is reviewing scientific evidence and will decide whether the vaccine platform should be different for the third dose, people with kno...
- BioNTech says three month interval between second and third COVID-19 shots warrantedChief Executive Officer Ugur Sahin said new data would prompt a discussion about bringing the third shot of its currently available vaccine...
- WHO European head backs third dose of coronavirus vaccine for the vulnerableDr. Hans Kluge cited "deeply worrying" levels of high transmission, saying 33 countries among the 53 in the WHO Europe region have reported...
Load More
